Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report.

Researchers suggest broadly reactive antibodies identified are likely to represent a common mechanism of acquired immunity to ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Scientists have created a novel technology for developing antibody (M6P) conjugates without enzyme modification in vitro, ...

Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable TherapeuticsJUPITER, Fla., Nov. 21, ...